Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Cilostazol MeSH Descriptor Data 2025


MeSH Heading
Cilostazol
Tree Number(s)
D03.383.129.617.293
D03.633.100.810.069
Unique ID
D000077407
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D000077407
Scope Note
A quinoline and tetrazole derivative that acts as a phosphodiesterase type 3 inhibitor, with anti-platelet and vasodilating activity. It is used in the treatment of PERIPHERAL VASCULAR DISEASES; ISCHEMIC HEART DISEASE; and in the prevention of stroke.
Entry Term(s)
6-(4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydro-2(1H)-quinolinone
OPC 13013
OPC-13013
Pletal
Pharm Action
Bronchodilator Agents
Fibrinolytic Agents
Platelet Aggregation Inhibitors
Vasodilator Agents
Neuroprotective Agents
Phosphodiesterase 3 Inhibitors
Registry Numbers
N7Z035406B
0
Related Numbers
73963-72-1
CAS Type 1 Name
2(1H)-Quinolinone, 6-(4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydro-
Public MeSH Note
2019; CILOSTAZOL was indexed under TETRAZOLES 1985-2018
History Note
2019 (1985)
Date Established
2019/01/01
Date of Entry
2018/07/09
Revision Date
2018/02/27
Cilostazol Preferred
OPC 13013 Narrower
Pletal Narrower
page delivered in 0.158s